Homozygous and compound heterozygous mutations in 17 genes, plus DAG1 itself, have been associated with dystroglycanopathies [15]. This evidence concerns the gene DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.